Large-scale testing (Phase 3)Study completedNCT00318448
What this trial is testing
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
Who this might be right for
Attention Deficit Hyperactivity Disorder
Sanofi 201